[Non-mutated neoantigens, TEIPP, as new targets for cancer immunotherapies]
- PMID: 32014105
- DOI: 10.1051/medsci/2019263
[Non-mutated neoantigens, TEIPP, as new targets for cancer immunotherapies]
References
-
- Schumacher TN Schreiber RD Neoantigens in cancer immunotherapy. Science 2015 ; 348 : 69–74.
-
- Aldous AR Dong JZ Personalized neoantigen vaccines: a new approach to cancer immunotherapy. Bio Med Chem 2018 ; 26 : 2842–2849.
-
- Cohen CJ Gartner JJ Horovitz-Fried M et al. Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes. J Clin Invest 2015 ; 125 : 3981–3991.
-
- Neefjes J Jongsma MLM Paul P et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Imm 2011 ; 11 : 823–836.
-
- Gros A Parkhurst MR Tran E et al. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat Med 2016 ; 22 : 433–438.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical